0001213900-21-012343.txt : 20210301 0001213900-21-012343.hdr.sgml : 20210301 20210301061318 ACCESSION NUMBER: 0001213900-21-012343 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210224 FILED AS OF DATE: 20210301 DATE AS OF CHANGE: 20210301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pankovcin Corinne CENTRAL INDEX KEY: 0001527535 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39336 FILM NUMBER: 21693604 MAIL ADDRESS: STREET 1: BUSINESS DEVELOPMENT CORP OF AMERICA STREET 2: 405 PARK AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aditx Therapeutics, Inc. CENTRAL INDEX KEY: 0001726711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823204328 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2569 WYANDOTTE, ST. STREET 2: SUITE 101 CITY: MOUNTAIN STATE: CA ZIP: 94043 BUSINESS PHONE: 909-488-0844 MAIL ADDRESS: STREET 1: 2569 WYANDOTTE, ST. STREET 2: SUITE 101 CITY: MOUNTAIN STATE: CA ZIP: 94043 FORMER COMPANY: FORMER CONFORMED NAME: ADiTx Therapeutics, Inc. DATE OF NAME CHANGE: 20171229 4 1 ownership.xml X0306 4 2021-02-24 0 0001726711 Aditx Therapeutics, Inc. ADTX 0001527535 Pankovcin Corinne C/O ADITX THERAPEUTICS, INC. 2569 WYANDOTTE ST., SUITE 101 MOUNTAIN VIEW CA 94043 0 1 0 0 CHIEF FINANCIAL OFFICER Common Stock 2021-02-24 4 A 0 110000 0 A 110000 D The restricted common stock shall vest in three (3) successive equal annual installments, beginning on March 31, 2021. /s/ Corinne Pankovcin 2021-03-01